Fully underwritten 31 for 47 at 35.8% discount to TERP. Gross proceeds of c. £1.2 bn, a placing by market volume, 40% dilution. Potential arbitrage opportunities. TP is 728p (5.3x EV/2023e EBITDA).
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.